Free shipping on all orders over $ 500

Tralokinumab

Cat. No. M24542

All AbMole products are for research use only, cannot be used for human consumption.

Tralokinumab Structure
Synonym:

CAT354

Size Price Availability Quantity
1mg USD 350 In stock
5mg USD 750 In stock
10mg USD 1200 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Tralokinumab, a fully human IgG4 monoclonal antibody, specifically binds with high affinity to IL-13 alone, preventing its interaction with the receptor and subsequent downstream signalling. Tralokinumab can be used for the research of the atopic dermatitis (AD).

Chemical Information
CAS Number 1044515-88-9
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Hannah A Blair. Clin Drug Investig. Tralokinumab in Atopic Dermatitis: A Profile of Its Use

[2] Sean Duggan. Drugs. Tralokinumab: First Approval

[3] Andreas Wollenberg, et al. J Dtsch Dermatol Ges. Tralokinumab in atopic dermatitis

[4] A Wollenberg, et al. Br J Dermatol. Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)

Related IL Receptor/Related Products
Reslizumab

Reslizumab (Sch 55700) is a humanized monoclonal antibody targeting human interleukin 5 (IL-5) for the study of eosinophilic asthma. Reslizumab effectively blocks il-5 function. Reslizumab inhibited IL-5-dependent cell proliferation with an IC50 of about 91.1 pM.

Montelukast sodium

Montelukast sodium selectively antagonizes leukotriene D 4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1.

VGX-1027

VGX-1027 is an orally active immunomodulator.

Diacerein

Diacerin is an inhibitor of pro-inflammatory cytokine Interleukin-1B (IL-1B) production, prescribed for osteoarthritis and chronic inflammatory arthritis.

SC144

SC144 is the first oral active GP130 (IL6-beta) inhibitor. SC144 binds gp130, induces gp130 phosphorylation (S782) and deglycosylation, eliminates Stat3 phosphorylation and nuclear translocation, and further inhibits downstream target gene expression. SC144 inhibited signal transduction induced by GP130 ligand. SC144 induces apoptosis of human ovarian cancer cells.

  Catalog
Abmole Inhibitor Catalog




Keywords: Tralokinumab, CAT354 supplier, IL Receptor/Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.